1. "Department of Medicine"
Formats
  1. Journal Article (19347)
  2. Meeting Abstract (15822)
  3. Review (1102)
  4. Book Section (924)
  5. Editorial (580)
  6. Research Letter (301)
  7. Conference Paper (299)
  8. Guidelines (285)
  9. Correspondence (226)
  10. Miscellaneous (87)
  11. Book Whole (61)
Groups
  1. Department of Medicine (39034)
  2. Solid Tumor Oncology Division (22035)
  3. Hematologic Malignancies, Division of (13003)
  4. Center for Hematologic Malignancies (10841)
  5. GSK Faculty (10529)
  6. Survivorship Research (9202)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Sergio Giralt (1050)
  4. Miguel-Angel Perales (913)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (642)
  2. 2024 (2141)
  3. 2023 (2451)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2560)

More Years

Publications
  1. Journal of Clinical Oncology (6050)
  2. Blood (3572)
  3. Annals of Oncology (1395)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (890)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6364)
  2. Elsevier Inc. (4610)
  3. American Society of Hematology (3843)
  4. American Association for Cancer Research (2879)
  5. Oxford University Press (2271)
  6. Nature Publishing Group (2080)

More Publishers

Results (39034)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant chemotherapy regimen selection in high-grade ovarian carcinoma: Comparing dose-dense chemotherapy with an every-three-week regimen
    Meeting Abstract

    Mueller, J.; Byrne, M.; Zhou, Q.; Iasonos, A.; Zivanovic, O.; Long Roche, K.; Tew, W.; Chi, D.; Gardner, G.; O'Cearbhaill, R.
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • Patterns of first recurrence of stage IIIC1 endometrial cancer with no para-aortic nodal dissection
    Meeting Abstract

    Aloisi, A.; Casanova Goncalves, J.; Tseng, J.; Seader, K.; Nguyen, N.; Alektiar, K.; Makker, V.; Soslow, R.; Leitao, M.; Abu-Rustum, N.
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • "Ultra low risk" endometrial cancer: Incidence and patterns of recurrence
    Meeting Abstract

    Stasenko, M.; Feit, N.; Seier, K.; Iasonos, A.; Soslow, R.; Cadoo, K.; Alektiar, K.; Leitao, M. M.; Gardner, G.; Abu-Rustum, N.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • Effect of prior bevacizumab therapy in patients with platinum-sensitive recurrent ovarian carcinoma (ROC) in the phase 3 study ARIEL3
    Meeting Abstract

    Oza, A.; Coleman, R. L.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A.; Scambia, G.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • GOG213
    Meeting Abstract

    Coleman, R. L.; Enserro, D.; Herzog, T. J.; Sabbatini, P.; Armstrong, D. K.; Kim, B.; Fujiwara, K.; Walker, J. L.; Spirtos, N.; Flynn, P. J.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • A phase III randomized controlled trial of secondary cytoreductive surgery (SCS) followed by platinum-based chemotherapy (PC) platinum-sensitive, recurrent ovarian cancer (PSOC) - Surgical parameters
    Meeting Abstract

    Coleman, R. L.; Enserro, D.; Herzog, T. J.; Sabbatini, P.; Armstrong, D. K.; Kim, B.; Fujiwara, K.; Walker, J. L.; Spirtos, N.; Flynn, P. J.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • NRG Oncology phase II randomized trial of nivolumab with or without ipilimumab in patients with persistent or recurrent ovarian cancer
    Meeting Abstract

    Burger, R.; Sill, M.; Zamarin, D.; Powell, D.; Frak, I.; Zivanovic, O.; Gunderson, C.; Ko, E.; Mathews, C.; Sharma, S.; more...
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • Safety and tolerability of the dual PI3K/mTOR inhibitor LY3023414 in treatment of patients with advanced mesothelioma
    Meeting Abstract

    Zauderer, M. G.; Hyman, D. M.; Alley, E. W.; Bendell, J. C.; Novello, S.; Bauer, T. M.; Hanauske, A. R.; Szpurka, A. M.; Kang, S.; Chatterjee, A.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis
    Meeting Abstract

    Yang, J.; Marass, F.; Ulz, P.; Shady, M.; Cheng, M. L.; Kothari, P.; Gedvilaite, E.; Somnay, S.; Shukla, N.; Modak, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Treatment with agonist anti-GITR antibody after chemotherapy enhances tumor immunity
    Meeting Abstract

    Warner, A. B.; Hirschhorn, D.; Cohen, A.; Liu, C.; Newman, W.; Sirard, C.; Wolchok, J.; Merghoub, T.
    Cancer Research (2018)

    Fulltext@MSK | Save